Skip to main content
TipRanks
Go Ultimate75% OFF

Biotest AG Insider Profile

4 Followers

Biotest AG, Ten Percent Owner at ADMA Biologics, holds 10.11M shares in ADMA Biologics (Ticker: ADMA).

Biotest AG's Trading History

ADMA
ADMA Biologics
May 16, 2018Ten Percent OwnerUninformative Sell―$128.69M
ADMA
Insider Shares: 10.11M (22.31%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 16, 2018Uninformative Sell$0.008,591,160$0.00―
Nov 13, 2017Informative Buy$12.50M5,813,954$2.15+106.00%
Jun 16, 2017Informative Buy―4,295,580$3.03+65.50%

You May Also Like

Biotest AG insider profile FAQ

What is the percentage of profitable transactions made by Biotest AG?
The percentage of profitable transactions made by Biotest AG is 100%.
What is the average return per transaction made by Biotest AG?
The average return per transaction made by Biotest AG is 85.70%.
What stocks does Biotest AG hold?
Biotest AG holds: ADMA stocks.
What was Biotest AG's most profitable transaction?
Biotest AG’s most profitable transaction was an Informative Buy of ADMA stock on November 13, 2017. The return on the trade was 106.00%.
What is Biotest AG's role in ADMA Biologics?
Biotest AG's role in ADMA Biologics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.